128 related articles for article (PubMed ID: 38088652)
41. Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice.
Chai Z; Dong H; Sun X; Fan Y; Wang Y; Huang F
Int J Biol Macromol; 2020 Sep; 159():640-647. PubMed ID: 32428589
[TBL] [Abstract][Full Text] [Related]
42. Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.
Zhao X; Shi A; Ma Q; Yan X; Bian L; Zhang P; Wu J
J Nanobiotechnology; 2021 Jun; 19(1):191. PubMed ID: 34176494
[TBL] [Abstract][Full Text] [Related]
43. Preparation, properties and challenges of the microneedles-based insulin delivery system.
Chen X; Wang L; Yu H; Li C; Feng J; Haq F; Khan A; Khan RU
J Control Release; 2018 Oct; 288():173-188. PubMed ID: 30189223
[TBL] [Abstract][Full Text] [Related]
44. [Effects of reactive oxygen species-responsive antibacterial microneedles on the full-thickness skin defect wounds with bacterial colonization in diabetic mice].
Zhang QR; Yang X; Li Z; Jia JZ; Luo GX; Yu YL; Zhang Y
Zhonghua Shao Shang Za Zhi; 2021 Nov; 37(11):1024-1035. PubMed ID: 34794254
[No Abstract] [Full Text] [Related]
45. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
Lau S; Fei J; Liu H; Chen W; Liu R
J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
[TBL] [Abstract][Full Text] [Related]
46. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
47. A composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():37-45. PubMed ID: 27612686
[TBL] [Abstract][Full Text] [Related]
48. Stimuli-responsive self-assembled dendrimers for oral protein delivery.
Zeng Z; Qi D; Yang L; Liu J; Tang Y; Chen H; Feng X
J Control Release; 2019 Dec; 315():206-213. PubMed ID: 31672623
[TBL] [Abstract][Full Text] [Related]
49. Glucose-Responsive Gold Nanocluster-Loaded Microneedle Patch for Type 1 Diabetes Therapy.
Zhang Y; Li J; Wu M; Guo Z; Tan D; Zhou X; Li Y; Liu S; Xue L; Lei Y
ACS Appl Bio Mater; 2020 Dec; 3(12):8640-8649. PubMed ID: 35019634
[TBL] [Abstract][Full Text] [Related]
50. A universal powder-laden crosslinked chitosan microneedle patch for high-dose controllable drug delivery.
He Y; Zang M; Zhang J; Cheng H; Cui Y; Wang D; Zhang H; Guan X; Wang S; Yuan Y; Gao Y
Int J Biol Macromol; 2024 Jan; 255():127988. PubMed ID: 37956809
[TBL] [Abstract][Full Text] [Related]
51. Biodegradable phenylboronic acid-modified ε-polylysine for glucose-responsive insulin delivery
Shen D; Yu H; Wang L; Chen X; Feng J; Zhang Q; Xiong W; Pan J; Han Y; Liu X
J Mater Chem B; 2021 Aug; 9(30):6017-6028. PubMed ID: 34259305
[TBL] [Abstract][Full Text] [Related]
52. H
Xu B; Jiang G; Yu W; Liu D; Zhang Y; Zhou J; Sun S; Liu Y
J Mater Chem B; 2017 Nov; 5(41):8200-8208. PubMed ID: 32264463
[TBL] [Abstract][Full Text] [Related]
53. A Fully Integrated Closed-Loop System Based on Mesoporous Microneedles-Iontophoresis for Diabetes Treatment.
Li X; Huang X; Mo J; Wang H; Huang Q; Yang C; Zhang T; Chen HJ; Hang T; Liu F; Jiang L; Wu Q; Li H; Hu N; Xie X
Adv Sci (Weinh); 2021 Aug; 8(16):e2100827. PubMed ID: 34081407
[TBL] [Abstract][Full Text] [Related]
54. Glucose-Responsive Chitosan Nanoparticle/Poly(vinyl alcohol) Hydrogels for Sustained Insulin Release
Ali A; Saroj S; Saha S; Gupta SK; Rakshit T; Pal S
ACS Appl Mater Interfaces; 2023 Jul; 15(27):32240-32250. PubMed ID: 37368956
[TBL] [Abstract][Full Text] [Related]
55. Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs.
Yu J; Wang J; Zhang Y; Chen G; Mao W; Ye Y; Kahkoska AR; Buse JB; Langer R; Gu Z
Nat Biomed Eng; 2020 May; 4(5):499-506. PubMed ID: 32015407
[TBL] [Abstract][Full Text] [Related]
56. Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.
Wang J; Ye Y; Yu J; Kahkoska AR; Zhang X; Wang C; Sun W; Corder RD; Chen Z; Khan SA; Buse JB; Gu Z
ACS Nano; 2018 Mar; 12(3):2466-2473. PubMed ID: 29455516
[TBL] [Abstract][Full Text] [Related]
57. Smart pH-responsive polymeric micelles for programmed oral delivery of insulin.
Hu WY; Wu ZM; Yang QQ; Liu YJ; Li J; Zhang CY
Colloids Surf B Biointerfaces; 2019 Nov; 183():110443. PubMed ID: 31445358
[TBL] [Abstract][Full Text] [Related]
58. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
59. Glucose-Responsive Microspheres as a Smart Drug Delivery System for Controlled Release of Insulin.
Yu J; Wang Q; Liu H; Shan X; Pang Z; Song P; Niu F; Hu L
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):113-121. PubMed ID: 31676984
[TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo assessment of polymer microneedles for controlled transdermal drug delivery.
Chen BZ; Ashfaq M; Zhang XP; Zhang JN; Guo XD
J Drug Target; 2018 Sep; 26(8):720-729. PubMed ID: 29301433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
